Big Pharma companies Novo Nordisk‚ Eli Lilly‚ and Sanofi have all lowered the cost of their name-brand exogenous insulin products to comply with a new regulation that caps monthly list prices at $35.00. This is the ballpark price for both the privately insured and those on Medicare‚ and does not take into account any rebates […] The post Outrageous Insulin Prices Now a Thing of the Past in U.S. After Government Initiates Monthly Cost of $35 appeared first on Good News Network.